FDA approves laser for refractive and cataract surgery

The FDA has approved Zeimer’s femtosecond laser device, femto LDV Z8. The mobile workstation is unique as it employs adjustable pulse energy and a high repetition rate to provide a precise capsulotomy and lens fragmentation.

The company says the femto LDV Z8 is approved for the following procedures: Z-LASIK, Z-LASIK Z, intracorneal rings, intrastromal pockets, lamellar keratoplasty, penetrating keratoplasty, anterior keratoplasty, lens fragmentation, clear corneal incisions and arc incisions.

“We are very excited to provide the femto LDV Z8 to the U.S. ophthalmic community,” David Bragg, president of Ziemer USA, said in the release. “The femto LDV lasers have proven to be powerful models for treating a broad variety of customizable, corneal treatments and embrace a strategy that grows with the surgeon’s practice.”

The femto LDV Z8 previously received CE approval in May 2014.